ArticleFrontiers in medicine2025

Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.

Jiaying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.